About TyRx
TyRx is a company based in Monmouth Junction (United States) founded in 1998 was acquired by Medtronic in January 2014. TyRx has raised $81.83 million across 10 funding rounds from investors including Medtronic, Boston Scientific and Comerica. The company has 42 employees as of December 31, 2022. TyRx operates in a competitive market with competitors including AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
- Headquarter Monmouth Junction, United States
- Employees 42 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tyrx, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TyRx
TyRx has successfully raised a total of $81.83M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $2 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TyRx
TyRx has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Boston Scientific and Comerica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in expansion stage tech and life sciences companies in the US
|
Locked | Locked | Locked | |
|
VC firm focusing on life science sector
|
Locked | Locked | Locked | |
|
Diversified investment management is provided across multiple asset classes.
|
Locked | Locked | Locked |
Investor details for TyRx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TyRx
Investment portfolio details for TyRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TyRx
Detailed financials for TyRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tyrx Comparisons
Peer comparison for TyRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TyRx
TyRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Mapping catheters for cardiac arrhythmia treatment are developed.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Detailed competitors of TyRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tyrx
Complete news archive for TyRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TyRx
TyRx was founded in 1998 and raised its 1st funding round 6 years after it was founded.
TyRx is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
TyRx is a funded company, having raised a total of $81.83M across 10 funding rounds to date.
As of Dec 31, 2022, the latest employee count at TyRx is 42.
TyRx was founded in 1998 in Monmouth Junction, United States, within the medical device sector. Antibacterial envelopes are produced by the company for cardiac implantable devices, with stabilization of implants and reduction of surgical site infections addressed through their design. Operations center on infection prevention for pacemaker and similar applications. Acquisition by Medtronic was completed in 2014.
TyRx's top competitors include AtaCor Medical, AtriCure and CardioFocus.
TyRx has 7 investors. Key investors include Medtronic, Boston Scientific, Comerica, Blackstone, and HLM Venture Partners.